Halozyme Therapeutics Q1 2026 Earnings EPS Beat Drives Modest Positive Surprise Despite Flat Revenue Disclosure Anteris Technologies Global Corp Q1 2026 Earnings EPS Misses Expectations as Stock Rises GROV Q1 2026 Earnings Strong EPS Beat Signals Operational Progress National Research Corporation NRC Q1 2026 Earnings EPS of 021 Reported Stock Sees Slight Decline NXST Q1 2026 Earnings Strong EPS Beat Amidst Modest Stock Decline as Nexstar Outperforms Estimates CIMP Q1 2026 Earnings EPS Beats Estimates by 282